Madrigal pharmaceuticals announces participation at three upcoming investor conferences

Conshohocken, pa., june 02, 2022 (globe newswire) -- madrigal pharmaceuticals, inc. (nasdaq: mdgl), a clinical-stage biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (nash), announced today its management team will participate in three upcoming investor conferences:

MDGL Ratings Summary

MDGL Quant Ranking